<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90484CE5-CEB3-4623-A1D6-2C470559BD39"><gtr:id>90484CE5-CEB3-4623-A1D6-2C470559BD39</gtr:id><gtr:name>Plaquetec Limited</gtr:name><gtr:address><gtr:line1>301 HARBOUR YARD , CHELSEA HARBOUR</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SW10 0XD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90484CE5-CEB3-4623-A1D6-2C470559BD39" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>90484CE5-CEB3-4623-A1D6-2C470559BD39</gtr:id><gtr:name>Plaquetec Limited</gtr:name><gtr:address><gtr:line1>301 HARBOUR YARD , CHELSEA HARBOUR</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>SW10 0XD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>100005.0</gtr:offerGrant><gtr:projectCost>166954.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/46C6D7AA-E8D7-47D2-99A8-62217F7E98DA"><gtr:id>46C6D7AA-E8D7-47D2-99A8-62217F7E98DA</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Blatcher</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=710778"><gtr:id>A8525329-BB1C-4983-A6C3-B091AB9BDF98</gtr:id><gtr:title>Proof of concept study on a novel manufacturing process and design features for a coronary artery liquid biopsy system</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Proof of Concept</gtr:grantCategory><gtr:grantReference>710778</gtr:grantReference><gtr:abstractText>Proof of Concept application for R&amp;amp;D on the design and manufacture of a novel, intra-arterial
catheter used to sample biomarkers associated with coronary artery disease (CAD). Initial
clinical studies with the device have uniquely shown that high concentrations of biomarkers
exist at sites of CAD. These biomarkers allow biological processes underlying the progression
of CAD to be better understood. PlaqueTec?s business model is to sell access to its coronary
biomarker IP &amp;amp; to provide bespoke studies to Pharmaceutical companies as a tool to a)
discover new drug targets and b) greatly de-risk the development of both novel and in pipeline
CVD drug therapies.
The applicant has regulatory approval to market its catheter in Europe and currently
manufactures the catheter using a short run batch release process. This is a largely manual
process that results in high production costs &amp;amp; limited throughput and this restricts broader
market uptake. The applicant seeks to simplify the production process using innovative design
&amp;amp; manufacturing technologies but at this stage the concepts are unproven. The enclosed
project seeks to provide the body of R&amp;amp;D needed to identify design/process improvements
that can deliver significant improvements in cost and throughput without compromising
compliance with medical device regulations.
This project is a study on the most safety critical element of the catheter, the deployable
mixing structures (termed ?baffles?). It will explore latest innovations in biomaterials, plasma
treatment, micromachining, joining &amp;amp; other manufacturing technologies to address three
main challenges 1 ? can design improvements deliver equivalent clinical performance to
current baffles at lower cost/higher throughput; 2 ? Can technology and process
improvements (e.g. semi automation) deliver the current baffle design more efficiently and 3
? Can methods be developed to demonstrate equivalence in baffle performance (post changes)
without requiring clinical trials.</gtr:abstractText><gtr:fund><gtr:end>2016-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>100005</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">710778</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>